Duodenal somatostatinoma and erythrocytosis in a patient with Von Hippel-Lindau disease type 2A

27Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

A female with von Hippel-Lindau (VHL) disease type 2A first presented with erythrocytosis at the age of 9 years. This patient revealed multiple paragangliomas at age 22. After the removal of tumors, a retinal hemangioblastoma developed. Our diagnosis of VHL disease type 2A was confirmed. Moreover, systemic examination showed a duodenal somatostatinoma. Frequent and long-term monitoring is important for patients with pheochromocytomas or paragangliomas, and a screening for VHL disease and other hereditary cancer syndromes is recommended. Recognition of neuroendocrine tumors as a manifestation of VHL disease permits earlier diagnosis and improves prognosis.

Cite

CITATION STYLE

APA

Karasawa, Y., Sakaguchi, M., Minami, S., Kitano, K., Kawa, S., Aoki, Y., … Kiyosawa, K. (2001). Duodenal somatostatinoma and erythrocytosis in a patient with Von Hippel-Lindau disease type 2A. Internal Medicine, 40(1), 38–43. https://doi.org/10.2169/internalmedicine.40.38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free